Thomas Brodowicz
Impact in
- Oncology top 10%
- Vascular Tumors and Angiosarcomas
- Rheumatology top 10%
- Urologic and reproductive health conditions
Papers in
- Oncology 20
- Vascular Tumors and Angiosarcomas 5
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
-
- Sarcoma Diagnosis and Treatment 13
- Co-authors
- Christoph Zielinski (16 shared papers)Wolfgang J. Köstler (9 shared papers)Michael Krainer (6 shared papers)Alexandra C. Budinsky (5 shared papers)Michael Hejna (5 shared papers)Michael Marberger (4 shared papers)Andreas Leithner (3 shared papers)Gabriele Amann (5 shared papers)
- Journals
- Anti-Cancer Drugs (5 papers)Journal of Clinical Oncology (3 papers)Cancer Immunology Immunotherapy (2 papers)Cancer (1 paper)Scientific Reports (1 paper)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Thomas Brodowicz
32 papers receiving 569 citations
Peers
Comparison fields: 5 of 77
- Oncology 242
- Rheumatology 131
- Pulmonary and Respiratory Medicine 264
- Gastroenterology 31
- Pathology and Forensic Medicine 92
Countries citing papers authored by Thomas Brodowicz
This map shows the geographic impact of Thomas Brodowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Brodowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Brodowicz more than expected).
Fields of papers citing papers by Thomas Brodowicz
This network shows the impact of papers produced by Thomas Brodowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Brodowicz. The network helps show where Thomas Brodowicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Brodowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 58 | |
| 2 | 1999 | 57 | |
| 3 | 2001 | 57 | |
| 4 | 2000 | 38 | |
| 5 | 1997 | 30 | |
| 6 | 2014 | 28 | |
| 7 | 2019 | 26 | |
| 8 | Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer. | 2004 | 25 |
| 9 | 2001 | 21 | |
| 10 | 2015 | 20 | |
| 11 | 2002 | 19 | |
| 12 | 2000 | 19 | |
| 13 | Recurrent malignant Triton tumour: first report on a long time survivor. | 2003 | 19 |
| 14 | 2017 | 16 | |
| 15 | 2001 | 15 | |
| 16 | 2013 | 14 | |
| 17 | 2016 | 13 | |
| 18 | 2008 | 13 | |
| 19 | 2000 | 11 | |
| 20 | 2015 | 10 |
About Thomas Brodowicz
Thomas Brodowicz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Rheumatology and Surgery, having authored 32 papers that have together received 577 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (13 papers), Cardiac tumors and thrombi (6 papers), Vascular Tumors and Angiosarcomas (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Bone Tumor Diagnosis and Treatments (3 papers). The work is most often cited by research in Oncology (242 citations), Rheumatology (131 citations), Pulmonary and Respiratory Medicine (264 citations), Gastroenterology (31 citations) and Pathology and Forensic Medicine (92 citations). Thomas Brodowicz has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Christoph Zielinski, Wolfgang J. Köstler, Michael Krainer, Alexandra C. Budinsky, Michael Hejna, Michael Marberger, Andreas Leithner, Gabriele Amann, Bernadette Liegl‐Atzwanger and Sandra Tomek. Their work appears in journals such as Anti-Cancer Drugs, Journal of Clinical Oncology, Cancer Immunology Immunotherapy, Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.